Long-Term Safety of Hydrocodone Bitartrate in Patients Who Require Opioid Treatment

Study Title
Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time
Teva Identifier
C33237/3080
ClinicalTrials.gov Identifier
NCT01223365
Study Status
Completed
Trial Condition(s)
Chronic Pain
Interventions
Drug: Hydrocodone ER

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 80 Years
Trial Duration
10/01/2010 - 09/01/2012
Phase
Phase 3

Study Type

Interventional